MedMira Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MMIRF research report →
Price Chart
About the company
MedMira Inc. is a leading biotechnology firm dedicated to the research, development, manufacturing, and global distribution of rapid diagnostic solutions and advanced technology platforms. The company's operations span North America, Europe, the Asia Pacific region, and other international territories.
- CEO
- Hermes Chan
- IPO
- 2009
- Employees
- 52
- HQ
- Halifax, NS, CA
Get TickerSpark's AI analysis on MMIRF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $27.93M
- P/E
- -14.77
- PEG
- -0.33
- P/S
- 123.09
- P/B
- -1.85
- EV/EBITDA
- -35.96
- Div Yield
- 0.00%
- Gross Margin
- -448.07%
- Op Margin
- -473.40%
- Net Margin
- -808.18%
- ROE
- 12.68%
- ROIC
- 24.72%
Latest fiscal year · YoY change
- Revenue
- $240.51K-41.7%
- Gross Profit
- $-714,736-415.6%
- Op Income
- $-3,589,747
- Net Income
- $-4,524,407-36.0%
- EPS
- $-0.00+2.1%
- OCF Growth
- -7.0%
- FCF Growth
- +14.3%
- 52W High
- $0.95
- 52W Low
- $0.00
- 50D MA
- $0.04
- 200D MA
- $0.03
- Beta
- 0.76
- RSI (14)
- 56
- Avg Volume
- 2.38K
No earnings-call transcripts are available for MMIRF yet.
- Free Float
- 29.9%
- Shares Outstanding
- 701.73M
- Float Shares
- 209.72M
Our MMIRF coverage
Recent articles, reports, and earnings notes.
No research on MMIRF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MMIRF report →MedMira Reports Third Quarter Results FY2026
accessnewswire.com · Jun 29
MedMira Reports Second Quarter Results FY2025
accessnewswire.com · Apr 1
MedMira Reports First Quarter Results FY2026
accessnewswire.com · Dec 30
MedMira Reports FY2025 Fourth Quarter and Year End Financial Results
accessnewswire.com · Nov 28
Health Canada Approves MedMira's Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis
accessnewswire.com · Aug 26
MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada
accessnewswire.com · Jul 7
MedMira Reports Second Quarter Results FY2025
accessnewswire.com · Jun 30
MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense
accessnewswire.com · Apr 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.